Unveiling a Drift Resistant Cryptotope within Marburgvirus Nucleoprotein Recognized by Llama Single-Domain Antibodies

John Anthony Garza1, Alexander Bryan Taylor2, Laura Jo Sherwood1

  • 1Department of Virology and Immunology, Texas Biomedical Research Institute, San Antonio, TX, United States.

Frontiers in Immunology
|October 18, 2017
PubMed

Insights

Researchers identified conserved epitopes on Marburg virus nucleoprotein using llama single-domain antibodies. These findings are crucial for developing diagnostics and therapeutics against this bioterror threat.

Area of Science:

  • Virology
  • Immunology
  • Structural Biology

Background:

  • Marburg virus (MARV) is a lethal hemorrhagic fever virus and a bioterror threat.
  • MARV's error-prone replication can lead to immune evasion.
  • Developing effective countermeasures requires understanding MARV's vulnerabilities.

Purpose of the Study:

  • To determine the epitopes of llama single-domain antibodies (sdAbs) targeting MARV nucleoprotein (NP).
  • To evaluate the potential of these sdAbs for diagnostic and therapeutic applications.

Main Methods:

  • Recombinant expression of MARV NP.
  • X-ray crystallography of antibody-antigen complexes.
  • Epitope mapping and structural analysis.

Main Results:

  • All four llama sdAbs bound the C-terminal region of MARV NP.
  • X-ray structures revealed a common epitope: a trio of alpha helices forming a unique basin-like depression.
  • sdAbs acted as crystallization chaperones for the NP C-terminal region.
  • MARV and Ebolavirus NP structures show homology but distinct epitope basin morphologies.
  • Naturally occurring MARV variations are distant from the antibody binding sites.

Conclusions:

  • The identified C-terminal NP epitope is conserved and likely cryptic, essential for virus replication.
  • Llama sdAbs targeting this conserved epitope offer a promising foundation for developing MARV diagnostics and therapeutics resistant to viral drift.

Related Concept Videos

Antibody Structure01:10

Antibody Structure

Overview
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
65.9K
Rab Proteins01:14

Rab Proteins

Rab proteins constitute the largest family of monomeric GTPases, of which 70 members are present in humans. Rab proteins and their effectors regulate consecutive stages of vesicle transport such as vesicle transport, docking, and fusion to the correct recipient membrane.
Rab proteins switch between a cytosolic, GDP-bound inactive state and a membrane-anchored, GTP-bound active state. By themselves, Rabs show slow rates of GDP/GTP exchange and GTP hydrolysis. Thus, Rab proteins are considered...
5.2K
Hybridoma Technology01:31

Hybridoma Technology

Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
17.9K